Once thought to be purely an endocrine disorder, a more modern understanding of insulin resistance and glycemic regulation has revealed that prediabetes, type 1 and type 2 diabetes are hugely related to cardiometabolic disease and its many comorbidities. As the understanding of how diabetes is related to conditions like obesity and heart failure grows, more therapeutic targets are being identified, showing promise for many new treatments.
Expert Highlights and Perspectives
Dietary Strategies for Reversing Type 2 Diabetes: Advances, Perspectives, and Expert Discussions
A Dr. Sarah Hallberg Legacy Course
This 4.5 hour, virtual webcast honored the late Dr. Sarah Hallberg by covering insights and practical strategies for the reversal of type 2 diabetes, with a focus on the role of low-carbohydrate interventions in this setting. Recorded on February 24, 2024.
-
Welcome and Introduction
Nina Teicholz, PhD & Ron Krauss, MD -
Definition & Pathophysiology of Type 2 Diabetes
Ben Bikman, PhD -
What Do We Mean by T2DM Reversal?
Nina Teicholz, PhD; Sarah Hallberg, DO, MS -
Metabolic Basis for Low-carbohydrate and Ketogenic Diets
Jeff Volek, PhD -
Clinical Trial Evidence for Type 2 Diabetes Reversal Through Dietary Approaches
Laura Saslow, PhD -
Practical Approaches to Implement and Maintain a Low-Carbohydrate Diet
Tony Hampton, MD; Ronesh Sinha, MD -
Patient Cases, Panel Discussion, and Audience Q&A
Moderators: Nina Teicholz, PhD & Ron Krauss, MD
Panelists: All faculty
MD
DUAL GLP-1/GIP AGONISTS: ARE THEY THE NEXT BIG THING IN DIABETES TREATMENT
(Recorded April 2022)
MD
HOW CAN WE CONVERGE THE GLUCOCENTRIC AND CARDIO-RENAL RISK MANAGEMENT IN DIABETES PATIENTS
(Recorded April 2022)
MD
MD
MD, PhD
MD, PhD
MD
MD
MD
MD
MD
Dietary Strategies for Reversing Type 2 Diabetes: Advances, Perspectives, and Expert Discussions
A Dr. Sarah Hallberg Legacy Course
This 4.5 hour, virtual webcast honored the late Dr. Sarah Hallberg by covering insights and practical strategies for the reversal of type 2 diabetes, with a focus on the role of low-carbohydrate interventions in this setting. Recorded on February 24, 2024.
-
Welcome and Introduction
Nina Teicholz, PhD & Ron Krauss, MD -
Definition & Pathophysiology of Type 2 Diabetes
Ben Bikman, PhD -
What Do We Mean by T2DM Reversal?
Nina Teicholz, PhD; Sarah Hallberg, DO, MS -
Metabolic Basis for Low-carbohydrate and Ketogenic Diets
Jeff Volek, PhD -
Clinical Trial Evidence for Type 2 Diabetes Reversal Through Dietary Approaches
Laura Saslow, PhD -
Practical Approaches to Implement and Maintain a Low-Carbohydrate Diet
Tony Hampton, MD; Ronesh Sinha, MD -
Patient Cases, Panel Discussion, and Audience Q&A
Moderators: Nina Teicholz, PhD & Ron Krauss, MD
Panelists: All faculty
News Digest
Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)
What happened at the 19th Annual CMHC? Get daily highlights, event photos, and read a poignant quote from keynote Dr. Peter Libby.
FDA Approves First Year-Long Continuous Glucose Monitoring Sensor for Diabetes
Discover the impact of this breaking FDA approval of the first year-long Continuous Glucose Monitoring sensor—READ NOW!
CMHC Presents at ADA 2024: Key Findings and Insights
Neha Agarwal, PhD, Clinical Director at Cardiometabolic Health Congress, Informa Connect, presented CME webcast study at ADA 2024.
The New Era of Continuous Glucose Monitoring (CGM) Expanding Access and Improving Outcomes
Explore advancements in OTC CGM systems. Plus, uncover the broader implications of these cutting-edge devices!
Cardiometabolic Health Congress Hosts the 2024 Women’s Masterclass in California to Advance Cardio-renal-metabolic Care for Women Â
5 Keys to Patient Education on GLP-1 RAs for Weight Loss
Comprehensive Overview of GLP-1 RAs in Cardiometabolic Care
Cardiometabolic Health Congress (CMHC) To Host DIETARY STRATEGIES FOR REVERSING TYPE 2 DIABETES: Advances, Perspectives, and Expert Discussions Live Webinar in Honor of the Late Dr. Sarah Hallberg
How to Get Free or Lower Cost Insulin for Your Medicare and Non-Medicare Patients: Shattering Barriers to Insulin Access
article
Care Delivery Implementation
This clinical brief was developed from a session at the 17th Annual Cardiometabolic Health Congress (CMHC) presented by Irl B Hirsch, MD from the University
article
Cardiometabolic Disease
The experts behind Cardiometabolic Health Congress have identified 10 stories in cardiorenal medicine to watch in 2023.
article
Diabetes
Sanofi was the last of three pharmaceutical goliaths to announce they’d make good on their long-spoken promise to lower the price of their insulin.
CME/CE Activities
Diabetes
Drug Pipeline
Drug Pipeline Coming Soon
#C1E5E9
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
#C1E5E9
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
#C1E5E9
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Resources
American Diabetes Association –
2022 Standards of Medical Care
in Diabetes
Diabetes Technology – Standards of Medical Care in Diabetes – 2022
Pharmacologic Approaches to
Glycemic Treatment: Standards of Medical Care in Diabetes – 2022
AACE: 2021 Advances Diabetes Technology Guideline
AHA Scientific Statement: Comprehensive Management of Cardiovascular Risk Factors For Adults with Type 2 Diabetes
Why Should We Use CGM in Patients With Type 2 Diabetes? Assessing the Evidence and Practical Pearls for Integration
